No, the MgSO₄ protocols for neuroprotection and eclampsia prophylaxis are NOT the same
The dosing regimens differ significantly between fetal neuroprotection and eclampsia prophylaxis/treatment, though there is ongoing debate about standardization across institutions.
Key Protocol Differences
For Eclampsia Prophylaxis/Treatment (Pritchard Regimen)
The FDA-approved protocol 1 consists of:
- Loading dose: 4-5 g IV over 3-4 minutes PLUS 10 g IM (5 g in each buttock)
- Maintenance: 4-5 g IM into alternate buttocks every 4 hours OR 1-2 g/hour continuous IV infusion
- Duration: Continue until 24 hours postpartum (though recent evidence questions this duration) 2
- Target serum level: 4-7.5 mEq/L for seizure control 1
For Fetal Neuroprotection
The protocol is typically:
- Loading dose: 4-6 g IV over 20-30 minutes
- Maintenance: 1-2 g/hour continuous IV infusion
- Duration: Until delivery (not continued postpartum for this indication)
- Gestational age: Used for imminent preterm birth <32-34 weeks (exact cutoff varies by institution) 3
Critical Clinical Distinctions
The indications are fundamentally different 4, 1:
- Eclampsia prophylaxis: Severe preeclampsia with maternal symptoms/severe features
- Fetal neuroprotection: Imminent preterm delivery regardless of preeclampsia status
A woman may receive BOTH indications simultaneously if she has severe preeclampsia AND is delivering preterm, but the protocols should not be confused 3.
Important Caveats
Institutional Variation
Research demonstrates significant protocol inconsistency across Canadian tertiary centers 3. Of 22 centers reviewed:
- Only 11 provided clear definitions for when to treat
- Criteria for treatment and monitoring varied substantially
- This lack of standardization persists despite published guidelines
Duration Controversy
Recent evidence 2 suggests shortened postpartum courses may be adequate for eclampsia prophylaxis, though the two eclamptic seizures that occurred in their meta-analysis were both in the <24-hour group, supporting continued use of the traditional 24-hour postpartum regimen.
Dosing Considerations
- Maximum daily dose: 30-40 g/24 hours 1
- Renal insufficiency: Maximum 20 g/48 hours with frequent serum monitoring 1
- Pregnancy duration: Do not exceed 5-7 days continuous use (causes fetal abnormalities) 1
Monitoring Requirements (Same for Both)
- Patellar reflexes (disappear at ~10 mEq/L)
- Respiratory rate (paralysis risk at ~10 mEq/L)
- Urine output (magnesium excreted renally) 1
- Have calcium gluconate available as antidote
The bottom line: These are distinct protocols for different indications that should not be used interchangeably, though a patient may qualify for both simultaneously.